Universal Ibogaine (TSX.V: IBO), a life sciences company with a mission to transform the addiction treatment industry with medicalized ibogaine-centered...
The article Top 3 Psychedelic Storylines to Watch in 2023 was originally published on Microdose. 2022 was a milestone year for the psychedelic industry...
Some analysts have called the industry's business model problematic. The post Despite Psychedelic Industry Buzz, Some Have Crashed Already appeared first...
Tryp Therapeutics, Inc. (CSE:TRYP | OTCQB:TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active...
The article Algernon Forms Private Subsidiary to Advance DMT Stroke Program was originally published on Microdose. “By creating AGN Neuro with the sole...
The market for IBS treatments is estimated to grow to $4.7 billion by 2030. The post Tryp Partners With Hospital For Psilocybin Study For IBS appeared...
With all the twists and turns coming from the U.S. federal government, decriminalization and legalization of psychedelics advancing all across the country,...
The article 2022 End-of-Year Review: MindMed was originally published on Microdose. Continuing our series of 2022 end-of-year reviews, we take a look...
Penny stocks to watch this week with news before 2023. The post Best Penny Stocks To Buy Before 2023? 4 To Watch Now appeared first on...
Global Psychiatrists Market Global Psychiatrists Market Dublin, Dec. 30, 2022 (GLOBE NEWSWIRE) -- The "Psychiatrists Global Market...